Home
Arthur A. Levin, Chief Scientific Officer: Avidity Biosciences RNA Sell · Filed 23/02/15
Trade details
- Type
- Insider sale
- Amount
- $223,846.74
- Shares · price
- 9,477 sh · $23.62 a share
- Held after
- 19,853 sh
- Trade date
- 23/02/14
- Filed
- 23/02/15
- Days to filing
- 1 days
Sold 32.3% of holdings
- Share of holding sold
- 32.3%
Avidity Biosciences trades, last 26 weeks
What else happened in Avidity Biosciences around then
Filed or reported within 30 days of the trade day · 23/01/15~23/03/16Arthur A. Levin's recent trades
- Arthur A. Levin
Sell10b5-1 planStoke Therapeutics
Sell10b5-1 planStoke Therapeutics
STOK
$22.3K
605 sh
$22.3K
Filed 03/17
Traded 03/13
- Arthur A. Levin
Planned sale10b5-1 planStoke Therapeutics
Planned sale10b5-1 planStoke Therapeutics
STOK
$22.1K
605 sh
$22.1K
Filed 03/13
Traded 03/13
- Arthur A. Levin
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 planAvidity Biosciences
RNA
$127.4K
1,758 sh
$127.4K
Filed 01/23
Traded 01/21
- Arthur A. Levin
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 planAvidity Biosciences
RNA
$5.1M
107,500 sh
$5.1M
Filed 25/08/08
Traded 25/08/06
- Arthur A. Levin
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 planAvidity Biosciences
RNA
$53.5K
1,872 sh
$53.5K
Filed 25/01/23
Traded 25/01/21
